TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Activity

811 hedge funds and large institutions have $30B invested in Teva Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 304 increasing their positions, 298 reducing their positions, and 75 closing their positions.

Holders
811
Holders Change
-23
Holders Change %
-2.76%
% of All Funds
21.67%
Holding in Top 10
41
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-22.64%
% of All Funds
1.1%
New
57
Increased
304
Reduced
298
Closed
75
Calls
$945M
Puts
$717M
Net Calls
+$228M
Net Calls Change
+$8.53M

Top Buyers

1
Barrow, Hanley, Mewhinney & Strauss
1
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.14B
2
PC
2
PointState Capital
New York
$751M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$867M
4
Franklin Resources
4
Franklin Resources
California
$2.07B
5
HCM
5
Highfields Capital Management
Massachusetts
$681M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.43B
2
Allianz Asset Management
2
Allianz Asset Management
Germany
$84M
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$1.39B
4
Invesco
4
Invesco
Georgia
$745M
5
PC
5
Paulson & Co
New York
$843M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.43B 68,350,458 -9,586,398 -12%
Franklin Resources
2
Franklin Resources
California
$2.07B 41,211,549 +4,389,590 +12%
Viking Global Investors
3
Viking Global Investors
Connecticut
$1.39B 27,736,655 -5,234,967 -16%
Barrow, Hanley, Mewhinney & Strauss
4
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.14B 22,700,812 +13,385,352 +144%
WRF
5
Waddell & Reed Financial
Kansas
$972M 19,358,468 +896,033 +5%
Capital Research Global Investors
6
Capital Research Global Investors
California
$867M 17,265,800 +5,722,500 +50%
PC
7
Paulson & Co
New York
$843M 16,773,800 -3,828,400 -19%
Lazard Asset Management
8
Lazard Asset Management
New York
$783M 15,586,863 +1,122,827 +8%
PC
9
PointState Capital
New York
$751M 14,951,660 +6,679,082 +81%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$747M 14,868,642 +1,972,944 +15%
Invesco
11
Invesco
Georgia
$745M 14,828,675 -4,077,251 -22%
Norges Bank
12
Norges Bank
Norway
$723M 14,387,639 +2,507,844 +21%
HCM
13
Highfields Capital Management
Massachusetts
$681M 13,549,525 +3,958,375 +41%
Nordea Investment Management
14
Nordea Investment Management
Sweden
$639M 12,719,749 +1,543,748 +14%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$452M 9,001,277 +194,662 +2%
BA
16
BlackRock Advisors
Delaware
$398M 7,922,181 +1,084,314 +16%
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$385M 7,667,414 +2,130,847 +38%
Schroder Investment Management Group
18
Schroder Investment Management Group
United Kingdom
$384M 7,654,733 +2,375,340 +45%
MIFH
19
Migdal Insurance & Financial Holdings
Israel
$375M 7,466,908 +3,594,209 +93%
JPMorgan Chase & Co
20
JPMorgan Chase & Co
New York
$365M 7,270,843 +1,664,452 +30%
Bank of America
21
Bank of America
North Carolina
$364M 7,239,135 -492,749 -6%
EVM
22
Eaton Vance Management
Massachusetts
$340M 6,764,560 +1,491,755 +28%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$308M 6,135,191 -269,555 -4%
Neuberger Berman Group
24
Neuberger Berman Group
New York
$304M 6,048,627 +817,492 +16%
SC
25
Sculptor Capital
New York
$272M 5,418,382 -2,629,924 -33%
1
2 3 4 5